Spleen Extract.

Glandular spleen material is a concentrated source of iron, and ascorbate reduces ferric iron to the ferrous form the DMT1 transporter accepts. Taken in the same dose it raises uptake of the non-heme portion.

Copper-dependent ceruloplasmin and hephaestin oxidise ferrous iron so it can be loaded onto transferrin and moved out of the enterocyte. Without adequate copper, iron from any source is not mobilised into circulation.

Calcium taken in the same dose interferes with iron transfer at the enterocyte and reduces absorption of both heme and non-heme forms. Separating a calcium dose from an iron-bearing glandular by a couple of hours avoids the competition.

Zinc and non-heme iron both move through DMT1, so a large dose of one lowers uptake of the other when they arrive together. Split dosing keeps each mineral working.

Iron supplies heme while B12 is required for DNA synthesis in dividing erythroid cells, so both are needed for normal red cell production. Supplying iron alone leaves the other half of the requirement open.

Folate provides the one-carbon units for thymidylate synthesis that dividing red cell precursors depend on, alongside the iron needed for haemoglobin. The two cover different rate limits in the same normal process.

Glandular material arrives as intact tissue protein, and stomach acid with pepsin is what unpacks it into absorbable peptides and frees bound iron. Formulators add acid support when gastric output is low so the extract is broken down.

Retinoid status affects the release of iron from hepatic stores and the response of developing red cells, a relationship documented in nutrition physiology. Spleen tissue supplies iron in heme form; vitamin A affects what happens to iron once it is inside the body. The two act at different points, so they are complementary rather than overlapping.

Riboflavin-derived flavins are required by enzymes involved in releasing iron from ferritin and in red cell metabolism, so poor riboflavin status limits how well supplied iron is used. This is a cofactor relationship rather than an absorption effect. Haemoglobin and ferritin readings are markers, not clinical outcomes.

Heme in animal tissue is bound to globin protein and has to be freed by gastric acid and pepsin before the heme molecule can be taken up by the intestinal epithelium. This is why low gastric acidity reduces iron uptake from meat and from tissue powders. Pepsin, and acid conditions generally, therefore sit upstream of anything spleen tissue can deliver.

Phytate from grains and legumes binds non-heme iron in the gut lumen and lowers how much is absorbed; phytase hydrolyses phytate and removes that binding. Heme iron is much less affected by phytate than non-heme iron is, so this partner matters mainly for the non-heme iron eaten in the same meal. The distinction between the two iron pools is the point.

Tannins form insoluble complexes with non-heme iron in the gut lumen, a well-quantified interaction behind the usual advice to separate tea from iron-containing meals. Heme iron is absorbed by a different route and is much less affected. The consequence is timing rather than incompatibility.

Green tea catechins bind non-heme iron in the gut and lower its absorption in the same dose window. Heme iron from animal tissue is comparatively insulated from that effect because it is taken up as an intact porphyrin. Separating the two by a couple of hours is the ordinary handling.

Calcium is unusual among iron inhibitors in that it reduces uptake of heme iron as well as non-heme iron, an effect measured in single-meal absorption studies. That makes it directly relevant to a heme-containing tissue powder. The interaction is dose-window dependent and is managed by separating intake.

Lactoferrin binds ferric iron tightly and delivers it through receptor-mediated routes distinct from the DMT1 pathway used for non-heme iron. Because it changes how iron is presented rather than adding more of the same pool, it is a modulating partner. How it interacts with heme iron from tissue powders specifically is not established.

Spleen tissue supplies heme iron, and an iron supplement supplies non-heme iron; both raise total iron intake even though they use different absorption routes. Absorbed iron is regulated on the way in by hepcidin and there is no regulated excretion route, so stacking two sources is worth flagging rather than assuming. This is an additive-intake note, not a recommendation about amounts.

Tocopherol terminates lipid radical chain reactions in membranes, including the red cell membrane, which is settled biochemistry. Iron participates in redox chemistry, so membrane antioxidant supply is discussed alongside iron intake. This is a mechanistic pairing and not a tested combination.

Glutathione peroxidase in red cells needs selenium in its active site to handle peroxides. That cofactor requirement stands on its own regardless of iron intake. Enzyme activity is a marker; changes in it are not by themselves clinical outcomes.